Exchange: NYSE·Updated 07:59 PM EST

HLN News

News
all
press releases
PG Raises Sales Outlook as Thorne Acquisition Adds Growth Potential
PG raises its sales outlook following the Thorne acquisition, but unchanged organic growth guidance, rising financing costs and restructuring risks temper optimism.
Zacks
PG Raises Sales Outlook as Thorne Acquisition Adds Growth Potential
PG raises its sales outlook following the Thorne acquisition, but unchanged organic growth guidance, rising financing costs and restructuring risks temper optimism.
Zacks
More News
Kimberly-Clark's Kenvue acquisition targets $2.1 billion in annual synergies, expanding its earnings potential, but integration costs and dilution pose near-term risks.
Zacks
Kimberly-Clark's discounted valuation and productivity gains offer support, but weak demand, earnings pressure and Kenvue integration risks favor a cautious stance.
Zacks
First Eagle Investment Management LLC lowered its stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 38.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 5,190,398 shares of the company's stock after selling 3,259,314 shares during the quarter. Fi...
MarketBeat
ASAIY vs. HLN: Which Stock Is the Better Value Option?
Zacks
Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommend...
MarketBeat
ASAIY vs. HLN: Which Stock Is the Better Value Option?
Zacks
Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't IgnorePR NewswireWARREN, N.J., Oct. 12, 2026Nostalgia-fueled experience introduces Excedrin Rapid Relief, providing fast relief of tough pain...
PR Newswire
LCUT vs. HLN: Which Stock Is the Better Value Option?
Zacks
Advil maker Haleon is capitalizing on the GLP-1 boom, boosting sales of products that combat weight loss drugs side effects with strategic store placement...
CNBC: Top News

Advertisement|Remove ads.